Chen Wenwei, Lu Kaixin, Liu Changyi, Weng Jinfeng, Gao Rui
Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Department of Urology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
J Endourol. 2025 Feb;39(2):135-145. doi: 10.1089/end.2024.0283. Epub 2024 Nov 26.
To evaluate the efficacy and safety of a novel tip-flexible suction ureteral access sheath (NTFS-UAS) combined with flexible ureteroscopic lithotripsy (FURS) for treating kidney stones ≥30 mm in a large cohort. The clinical data of 206 patients with renal calculi ≥30 mm treated by NTFS-UAS combined with FURS from June 2021 to September 2023 were analyzed retrospectively. The outcomes under investigation encompassed demographic information, stone-related characteristics, operative time, stone-free rates (SFRs), and postoperative complications. The median operation duration was 110 minutes (interquartile 84.00-146.25 minutes). Immediate and 1-month SFRs were 83.98% and 85.44%, respectively. Multivariate analysis revealed five risk factors independently affecting stone clearance rate: stone size (≥50 mm, odds ratio [OR] = 3.826, = 0.039), stone number (multiple: OR = 8.745, = 0.015), stone location (multiple calyces: OR = 10.371, = 0.045; lower calyx: OR = 9.615, = 0.047), severe hydronephrosis (OR = 8.338, = 0.002), and the Resorlu-Unsal scoring system (RUSS) score (6-7: OR = 10.829, = 0.009; 4-5: OR = 4.223, = 0.008). The incidence of Clavien-Dindo grade II-III complication was 5.82%. Positive preoperative urine culture (OR = 9.533, = 0.012) and RUSS score (6-7: OR = 25.678, = 0.026; 4-5: OR = 11.444, = 0.038) were identified as the most important variables that may contribute to the development of high-grade postoperative complications. NFTS-UAS combined with FURS achieved satisfactory outcomes with good efficacy and safety for treating large renal stones ≥30 mm, and it can be utilized as an effective treatment option for patients having contraindications or preference against percutaneous nephrolithotomy. In addition, clinical factors, such as stone size, severe hydronephrosis, positive preoperative urine culture, and RUSS stone score that likely affected the outcomes of NFTS-UAS, should be fully taken into account when the surgeon performing FURS using NFTS-UAS.
为了在一个大型队列中评估新型尖端可弯曲输尿管鞘(NTFS-UAS)联合软性输尿管镜碎石术(FURS)治疗直径≥30mm肾结石的疗效和安全性。回顾性分析了2021年6月至2023年9月期间采用NTFS-UAS联合FURS治疗的206例直径≥30mm肾结石患者的临床资料。研究的结果包括人口统计学信息、结石相关特征、手术时间、无石率(SFR)和术后并发症。中位手术时间为110分钟(四分位间距84.00 - 146.25分钟)。即刻和1个月时的SFR分别为83.98%和85.44%。多因素分析显示有五个独立影响结石清除率的危险因素:结石大小(≥50mm,比值比[OR]=3.826,P = 0.03),结石数量(多发:OR = 8.745,P = 0.015),结石位置(多个肾盏:OR = 10.371,P = 0.045;下肾盏:OR = 9.615,P = 0.047),重度肾积水(OR = 8.338,P = 0.002)以及Resorlu-Unsal评分系统(RUSS)评分(6 - 7分:OR = 10.829,P = 0.009;4 - 5分:OR = 4.223,P = 0.008)。Clavien-Dindo II - III级并发症的发生率为5.82%。术前尿培养阳性(OR = 9.533,P = 0.012)和RUSS评分(6 - 7分:OR = 25.678,P = 0.026;4 - 5分:OR = 11.444,P = 0.038)被确定为可能导致高级别术后并发症发生的最重要变量。NTFS-UAS联合FURS治疗直径≥30mm的大肾结石取得了满意的疗效和安全性,对于有经皮肾镜取石术禁忌证或偏好的患者,它可作为一种有效的治疗选择。此外,在外科医生使用NTFS-UAS进行FURS时,应充分考虑可能影响NTFS-UAS治疗效果的临床因素,如结石大小、重度肾积水、术前尿培养阳性以及RUSS结石评分。